Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Chemokine CXCL9"" wg kryterium: Temat


Tytuł :
Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice.
Autorzy :
Allred MG; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.; Immunology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.
Chimenti MS; Iowa Institute of Human Genetics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Ciecko AE; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Max McGee National Research Center for Juvenile Diabetes, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Chen YG; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Max McGee National Research Center for Juvenile Diabetes, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Lieberman SM; Stead Family Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.; Immunology Graduate Program, University of Iowa, Iowa City, IA 52242, USA.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 05; Vol. 22 (7). Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Chemokine CXCL10/*immunology
Chemokine CXCL9/*immunology
Interleukins/*immunology
Lacrimal Apparatus/*immunology
Signal Transduction/*immunology
T-Lymphocytes, Regulatory/*immunology
Animals ; Chemokine CXCL10/genetics ; Chemokine CXCL9/genetics ; Inflammation/genetics ; Inflammation/immunology ; Inflammation/pathology ; Interleukins/genetics ; Lacrimal Apparatus/pathology ; Mice ; Mice, Inbred NOD ; Mice, Knockout ; Receptors, CXCR3/genetics ; Receptors, CXCR3/immunology ; Signal Transduction/genetics ; T-Lymphocytes, Regulatory/pathology
Czasopismo naukowe
Tytuł :
CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Autorzy :
Kameda M; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Otsuka M; Department of Respiratory Medicine, Sapporo-Kosei General Hospital, Sapporo, Hokkaido, Japan.
Chiba H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Kuronuma K; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Hasegawa T; Sysmex Corporation, Kobe, Japan.
Takahashi H; Department of Rheumatology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Takahashi H; Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Nov 02; Vol. 15 (11), pp. e0241719. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers/*blood
Chemokine CXCL10/*blood
Chemokine CXCL11/*blood
Chemokine CXCL9/*blood
Lung Diseases, Interstitial/*diagnosis
Vascular Diseases/*complications
Aged ; Autoimmunity ; Biomarkers/analysis ; Bronchoalveolar Lavage Fluid/chemistry ; Bronchoalveolar Lavage Fluid/cytology ; Bronchoalveolar Lavage Fluid/immunology ; C-Reactive Protein/analysis ; Chemokine CXCL10/analysis ; Chemokine CXCL11/analysis ; Chemokine CXCL9/analysis ; Collagen/metabolism ; Female ; Humans ; Idiopathic Pulmonary Fibrosis/diagnosis ; Lung Diseases, Interstitial/etiology ; Lymphocytes/cytology ; Lymphocytes/metabolism ; Macrophages/cytology ; Macrophages/metabolism ; Male ; Middle Aged ; Retrospective Studies ; Vascular Diseases/pathology ; Vital Capacity
Czasopismo naukowe
Tytuł :
Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model.
Autorzy :
Phan QT; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Tan WH; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Liu R; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Sundaram S; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Buettner A; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Kneitz S; Department of Developmental Biochemistry, Biocenter, University of Würzburg, 97080 Würzburg, Germany.
Cheong B; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Vyas H; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Mathavan S; Genome Institute of Singapore, Singapore 138672, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 639798, Singapore.
Schartl M; Department of Developmental Biochemistry, Biocenter, University of Würzburg, 97080 Würzburg, Germany.; The Xiphophorus Genetic Stock Center, Department of Chemistry and Biochemistry, Texas State University, San Marcos, TX 78666.
Winkler C; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore; .; Centre for Bioimaging Sciences, National University of Singapore, Singapore 117543, Singapore.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Aug 11; Vol. 117 (32), pp. 19276-19286. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bone Matrix/*metabolism
Chemokine CXCL9/*metabolism
Fish Proteins/*metabolism
Oryzias/*metabolism
Osteoclasts/*metabolism
Osteoporosis/*metabolism
Receptors, CXCR3/*metabolism
Stem Cells/*metabolism
Animals ; Bone Matrix/growth & development ; Cell Differentiation ; Chemokine CXCL9/genetics ; Disease Models, Animal ; Fish Proteins/genetics ; Humans ; Macrophages/metabolism ; Oryzias/genetics ; Oryzias/growth & development ; Osteoblasts/cytology ; Osteoblasts/metabolism ; Osteoclasts/cytology ; Osteoporosis/genetics ; Osteoporosis/physiopathology ; Protein Binding ; Receptors, CXCR3/genetics ; Stem Cells/cytology
Czasopismo naukowe
Tytuł :
Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9.
Autorzy :
Erez DL; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: .
Denburg MR; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Afolayan S; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Jodele S; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Wallace G; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Davies SM; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Seif AE; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Bunin N; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Laskin BL; Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Sullivan KE; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Jul; Vol. 26 (7), pp. 1266-1272. Date of Electronic Publication: 2020 Mar 09.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Kidney Injury*/diagnosis
Acute Kidney Injury*/etiology
Chemokine CXCL10*/urine
Chemokine CXCL9*/urine
Hematopoietic Stem Cell Transplantation*/adverse effects
Biomarkers ; Child ; Child, Preschool ; Creatinine ; HEK293 Cells ; Humans ; Male ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Study on the relationship between CXCR3 and its ligands and tubal tuberculosis.
Autorzy :
Sun H; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, China; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Fan J; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, China; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Shang X; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, China.
Tuohetaerbaike B; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Li Y; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Lv J; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Wang Y; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Wang L; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
Wang J; First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China; Respiratory Department of the Second Affiliated Hospital of Hainan Medical College, Haikou, Hainan 570000, China. Electronic address: .
Ma X; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 May 01; Vol. 272, pp. 119047. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Fallopian Tubes/*microbiology
Receptors, CXCR3/*metabolism
Tuberculosis, Female Genital/*metabolism
Adult ; Chemokine CXCL10/metabolism ; Chemokine CXCL11/metabolism ; Chemokine CXCL9/metabolism ; Chemokines ; China ; Epithelial Cells/metabolism ; Fallopian Tubes/pathology ; Female ; Granuloma/metabolism ; Humans ; Ligands ; Middle Aged ; Receptors, CXCR3/physiology ; Tuberculosis/metabolism ; Tuberculosis, Female Genital/physiopathology
Czasopismo naukowe
Tytuł :
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer.
Autorzy :
Romero JM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Grünwald B; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Jang GH; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Bavi PP; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Jhaveri A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Masoomian M; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Fischer SE; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Zhang A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Denroche RE; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Lungu IM; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
De Luca A; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Bartlett JMS; Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Xu J; Drug Development Program Biomarker Laboratory, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Li N; UHN Biobank, University Health Network, Toronto, Ontario, Canada.
Dhaliwal S; UHN Biobank, University Health Network, Toronto, Ontario, Canada.
Liang SB; UHN Biobank, University Health Network, Toronto, Ontario, Canada.
Chadwick D; UHN Biobank, University Health Network, Toronto, Ontario, Canada.
Vyas F; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Bronsert P; Tumorbank Comprehensive Cancer Center Freiburg, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute for Surgical Pathology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Khokha R; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
McGaha TL; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Notta F; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Ohashi PS; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Done SJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
O'Kane GM; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Wallace McCain Centre of Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Wilson JM; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Knox JJ; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Wallace McCain Centre of Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Connor A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Wang Y; The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; The Goodman Cancer Research Centre of McGill University, Montréal, Québec, Canada.
Zogopoulos G; The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.; The Goodman Cancer Research Centre of McGill University, Montréal, Québec, Canada.
Gallinger S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. .; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Wallace McCain Centre of Pancreatic Cancer, Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; Hepatobilliary Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Apr 15; Vol. 26 (8), pp. 1997-2010. Date of Electronic Publication: 2020 Jan 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*genetics
CD8-Positive T-Lymphocytes/*immunology
Chemokine CCL4/*genetics
Chemokine CCL5/*genetics
Chemokine CXCL10/*genetics
Chemokine CXCL9/*genetics
Liver Neoplasms/*secondary
Pancreatic Neoplasms/*pathology
Biomarkers, Tumor/immunology ; Chemokine CCL4/immunology ; Chemokine CCL5/immunology ; Chemokine CXCL10/immunology ; Chemokine CXCL9/immunology ; Cohort Studies ; Computational Biology/methods ; Databases, Genetic/statistics & numerical data ; Humans ; Immune Checkpoint Proteins/genetics ; Immunotherapy/methods ; Liver Neoplasms/genetics ; Liver Neoplasms/immunology ; Mutation ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/immunology ; RNA-Seq/methods
Czasopismo naukowe
Tytuł :
Cordycepin Attenuates IFN-γ-Induced Macrophage IP-10 and Mig Expressions by Inhibiting STAT1 Activity in CFA-Induced Inflammation Mice Model.
Autorzy :
Yang R; Department of Immunology, School of Preclinical Medicine, Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China. .
Wang X; Department of Immunology, School of Preclinical Medicine, Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Xi D; Department of Immunology, School of Preclinical Medicine, Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Mo J; Department of Immunology, School of Preclinical Medicine, Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Wang K; Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Luo S; Department of Immunology, School of Preclinical Medicine, Center for Genomic and Personalized Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Wei J; Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Ren Z; State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, National Engineering Research Center of South China Sea Marine Biotechnology, Department of Biochemistry, College of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, People's Republic of China.
Pang H; Department of Physiology, School of Preclinical Medicine, Guangxi Medical University, 22 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.
Luo Y; Department of Clinical Laboratory, Peoples's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People's Republic of China. .
Pokaż więcej
Źródło :
Inflammation [Inflammation] 2020 Apr; Vol. 43 (2), pp. 752-764.
Typ publikacji :
Journal Article
MeSH Terms :
Chemokine CXCL10/*antagonists & inhibitors
Chemokine CXCL9/*antagonists & inhibitors
Deoxyadenosines/*therapeutic use
Interferon-gamma/*toxicity
Macrophages/*drug effects
STAT1 Transcription Factor/*antagonists & inhibitors
Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Chemokine CXCL10/biosynthesis ; Chemokine CXCL9/biosynthesis ; Deoxyadenosines/pharmacology ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Female ; Freund's Adjuvant/toxicity ; Gene Expression ; Inflammation/chemically induced ; Inflammation/drug therapy ; Inflammation/metabolism ; Macrophages/metabolism ; Mice ; RAW 264.7 Cells ; Random Allocation ; STAT1 Transcription Factor/metabolism
Czasopismo naukowe
Tytuł :
CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression.
Autorzy :
Gao HF; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Cheng CS; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Tang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Li Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Chen H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Meng ZQ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Chen Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Chen LY; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Pokaż więcej
Źródło :
Aging [Aging (Albany NY)] 2020 Jan 08; Vol. 12 (1), pp. 502-517. Date of Electronic Publication: 2020 Jan 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma/*immunology
Adenocarcinoma/*metabolism
Chemokine CXCL9/*metabolism
Pancreatic Neoplasms/*immunology
Pancreatic Neoplasms/*metabolism
STAT3 Transcription Factor/*immunology
T-Lymphocytes, Cytotoxic/*immunology
T-Lymphocytes, Cytotoxic/*metabolism
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Animals ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/pathology ; Cell Line, Tumor ; Chemokine CXCL9/genetics ; Chemokine CXCL9/pharmacology ; Disease Models, Animal ; Disease Progression ; Gene Expression ; Humans ; Immunomodulation ; Immunophenotyping ; Lymphocyte Activation/drug effects ; Lymphocyte Activation/immunology ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Mice ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Prognosis ; Recombinant Proteins/pharmacology ; Signal Transduction ; T-Lymphocytes, Cytotoxic/drug effects ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Autorzy :
Abers MS; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Delmonte OM; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Ricotta EE; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Fintzi J; Biostatistics Research Branch, NIAID, NIH, Bethesda, Maryland, USA.
Fink DL; Neutrophil Monitoring Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
de Jesus AAA; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Zarember KA; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Alehashemi S; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Oikonomou V; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Desai JV; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Canna SW; Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Shakoory B; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Dobbs K; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Imberti L; CREA Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
Sottini A; CREA Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
Quiros-Roldan E; Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.
Castelli F; Department of Infectious and Tropical Diseases, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy.
Rossi C; Direzione Sanitaria, ASST Spedali Civili di Brescia, Italy.
Brugnoni D; Laboratorio Analisi Chimico-Cliniche, ASST Spedali Civili, Brescia, Italy.
Biondi A; Pediatric Department and Centro Tettamanti-European Reference Network on Paediatric Cancer, European Reference Network on Haematological Diseases, and European Reference Network on Hereditary Metabolic Disorders-University of Milano-Bicocca-Fondazione MBBM, Monza, Italy.
Bettini LR; Pediatric Department and Centro Tettamanti-European Reference Network on Paediatric Cancer, European Reference Network on Haematological Diseases, and European Reference Network on Hereditary Metabolic Disorders-University of Milano-Bicocca-Fondazione MBBM, Monza, Italy.
D'Angio' M; Pediatric Department and Centro Tettamanti-European Reference Network on Paediatric Cancer, European Reference Network on Haematological Diseases, and European Reference Network on Hereditary Metabolic Disorders-University of Milano-Bicocca-Fondazione MBBM, Monza, Italy.
Bonfanti P; Department of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.
Castagnoli R; Department of Pediatrics and.
Montagna D; Laboratory of Immunology and Transplantation, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
Licari A; Department of Pediatrics and.
Marseglia GL; Department of Pediatrics and.
Gliniewicz EF; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Shaw E; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Kahle DE; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Rastegar AT; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Stack M; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Myint-Hpu K; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Levinson SL; BioAegis Therapeutics, Inc, North Brunswick, New Jersey, USA.
DiNubile MJ; BioAegis Therapeutics, Inc, North Brunswick, New Jersey, USA.
Chertow DW; Critical Care Medicine Department, NIH Clinical Center, NIH, Bethesda, Maryland, USA.
Burbelo PD; National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland, USA.
Cohen JI; Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
Calvo KR; Hematology Section, Department of Laboratory Medicine, NIH Clinical Center, NIH, Bethesda, Maryland, USA.
Tsang JS; Laboratory of Immune System Biology and Clinical Genomics Program, NIAID, NIH, Bethesda, Maryland, USA.; Center for Human Immunology, Autoimmunity, and Inflammation, NIAID, NIH, Bethesda, Maryland, USA.
Su HC; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Gallin JI; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Kuhns DB; Neutrophil Monitoring Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Goldbach-Mansky R; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Lionakis MS; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Pokaż więcej
Corporate Authors :
NIAID COVID-19 Consortium
Źródło :
JCI insight [JCI Insight] 2021 Jan 11; Vol. 6 (1). Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :
COVID-19/*immunology
COVID-19/*mortality
Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Anti-Bacterial Agents/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; Azithromycin/therapeutic use ; Biomarkers ; COVID-19/genetics ; COVID-19/therapy ; Calgranulin B/genetics ; Calgranulin B/immunology ; Case-Control Studies ; Chemokine CCL2/genetics ; Chemokine CCL2/immunology ; Chemokine CXCL9/genetics ; Chemokine CXCL9/immunology ; Enzyme Inhibitors/therapeutic use ; Female ; Ferritins/genetics ; Ferritins/immunology ; Gene Expression Profiling ; Humans ; Hydroxychloroquine/therapeutic use ; Immunologic Factors/therapeutic use ; Interferon Type I/genetics ; Interferon Type I/immunology ; Interferon-gamma/genetics ; Interferon-gamma/immunology ; Interleukin-1 Receptor-Like 1 Protein/genetics ; Interleukin-1 Receptor-Like 1 Protein/immunology ; Interleukin-10/genetics ; Interleukin-10/immunology ; Interleukin-15/genetics ; Interleukin-15/immunology ; Interleukin-2/genetics ; Interleukin-2/immunology ; Interleukin-6/genetics ; Interleukin-6/immunology ; Lactoferrin/genetics ; Lactoferrin/immunology ; Lipocalin-2/genetics ; Lipocalin-2/immunology ; Male ; Matrix Metalloproteinase 9/genetics ; Matrix Metalloproteinase 9/immunology ; Middle Aged ; Multivariate Analysis ; NF-kappa B/genetics ; NF-kappa B/immunology ; Prognosis ; Receptors, Tumor Necrosis Factor, Type I/genetics ; Receptors, Tumor Necrosis Factor, Type I/immunology ; SARS-CoV-2 ; Severity of Illness Index ; Vascular Endothelial Growth Factor Receptor-1/genetics ; Vascular Endothelial Growth Factor Receptor-1/immunology
Czasopismo naukowe
Tytuł :
Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Autorzy :
Li Q; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Sun J; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Cao Y; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Liu B; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Li L; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Mohammadtursun N; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Zhang H; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China.
Dong J; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Institutes of Integrative Medicine, Fudan University, Shanghai, 200040, China. Electronic address: .
Wu J; Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200040, China. Electronic address: .
Pokaż więcej
Źródło :
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Mar; Vol. 123, pp. 109735. Date of Electronic Publication: 2019 Dec 18.
Typ publikacji :
Journal Article
MeSH Terms :
Chemokine CXCL10/*metabolism
Chemokine CXCL11/*metabolism
Chemokine CXCL9/*metabolism
Drugs, Chinese Herbal/*pharmacology
Receptors, CXCR3/*metabolism
T-Lymphocytes/*drug effects
Animals ; Chemokine CXCL10/genetics ; Chemokine CXCL11/genetics ; Chemokine CXCL9/genetics ; Gene Expression Regulation/drug effects ; Humans ; Lung/drug effects ; Lung/metabolism ; Lung/pathology ; Male ; Pulmonary Disease, Chronic Obstructive/chemically induced ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Random Allocation ; Rats ; Receptors, CXCR3/genetics ; Transcriptome
Czasopismo naukowe
Tytuł :
Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma.
Autorzy :
Fukuda Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Asaoka T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Eguchi H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yokota Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Kubo M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Kinoshita M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Urakawa S; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Iwagami Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Tomimaru Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Akita H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Noda T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Gotoh K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Kobayashi S; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Hirata M; Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Toyonaka, Japan.
Wada H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.; Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan.
Mori M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2020 Feb; Vol. 111 (2), pp. 323-333. Date of Electronic Publication: 2020 Jan 23.
Typ publikacji :
Journal Article
MeSH Terms :
Bile Duct Neoplasms/*pathology
Chemokine CXCL9/*metabolism
Cholangiocarcinoma/*pathology
Killer Cells, Natural/*metabolism
Lymphocytes, Tumor-Infiltrating/*metabolism
Animals ; Bile Duct Neoplasms/immunology ; Bile Duct Neoplasms/surgery ; Biomarkers, Tumor/metabolism ; Cell Line, Tumor ; Chemokine CXCL9/antagonists & inhibitors ; Cholangiocarcinoma/immunology ; Cholangiocarcinoma/surgery ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Male ; Mice ; Prognosis ; RNA, Small Interfering/administration & dosage ; RNA, Small Interfering/pharmacology ; Up-Regulation
Czasopismo naukowe
Tytuł :
The Role of CXCL13 and CXCL9 in Early Breast Cancer.
Autorzy :
Razis E; Third Department of Medical Oncology, Hygeia Hospital, Athens, Greece. Electronic address: .
Kalogeras KT; Translational Research Section, Hellenic Cooperative Oncology Group, Athens, Greece; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kotsantis I; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
Manousou K; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece.
Wirtz R; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
Veltrup E; STRATIFYER Molecular Pathology GmbH, Cologne, Germany.
Patsea H; Department of Pathology, IASSO General Hospital, Athens, Greece.
Poulakaki N; Breast Surgery Clinic, Euroclinic, Athens, Greece.
Dionysopoulos D; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
Pervana S; Department of Pathology, Papageorgiou Hospital, Thessaloniki, Greece.
Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece.
Pentheroudakis G; Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece.
Christodoulou C; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
Linardou H; Oncology Unit, Metropolitan Hospital, Piraeus, Greece.
Pavlakis K; Pathology Department, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Koletsa T; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece.
Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pokaż więcej
Źródło :
Clinical breast cancer [Clin Breast Cancer] 2020 Feb; Vol. 20 (1), pp. e36-e53. Date of Electronic Publication: 2019 Sep 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*mortality
Chemokine CXCL13/*metabolism
Chemokine CXCL9/*metabolism
Lymphocytes, Tumor-Infiltrating/*immunology
Adult ; Aged ; Biomarkers, Tumor/analysis ; Breast/immunology ; Breast/pathology ; Breast/surgery ; Breast Neoplasms/immunology ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Chemokine CXCL13/analysis ; Chemokine CXCL9/analysis ; Disease-Free Survival ; Female ; Follow-Up Studies ; Gene Expression Profiling ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Mastectomy ; Middle Aged ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Tissue Array Analysis ; Tumor Microenvironment/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.
Autorzy :
Arger NK; University of California, San Francisco, Division of Pulmonary and Critical Care, 505 Parnassus Ave, San Francisco, CA, 94143, USA. Electronic address: .
Ho ME; University of California, San Francisco, Division of Pulmonary and Critical Care, 505 Parnassus Ave, San Francisco, CA, 94143, USA.
Allen IE; University of California, San Francisco, Department of Epidemiology and Biostatistics, 550 16thSt, San Francisco, CA, 94158, USA.
Benn BS; University of California, San Francisco, Division of Pulmonary and Critical Care, 505 Parnassus Ave, San Francisco, CA, 94143, USA.
Woodruff PG; University of California, San Francisco, Division of Pulmonary and Critical Care, 505 Parnassus Ave, San Francisco, CA, 94143, USA.
Koth LL; University of California, San Francisco, Division of Pulmonary and Critical Care, 505 Parnassus Ave, San Francisco, CA, 94143, USA.
Pokaż więcej
Źródło :
Respiratory medicine [Respir Med] 2020 Jan; Vol. 161, pp. 105822. Date of Electronic Publication: 2019 Nov 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Genetic Association Studies*
Chemokine CXCL10/*blood
Chemokine CXCL9/*blood
Sarcoidosis, Pulmonary/*genetics
Adult ; Chemokine CXCL10/genetics ; Chemokine CXCL9/genetics ; Female ; Gene Expression ; Humans ; Male ; Middle Aged ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome.
Autorzy :
Caldarale F; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Giacomelli M; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Garrafa E; Department of Molecular and translational Medicin and Clinical Chemistry Laboratory ASST Spedali Civili, Brescia, Italy.
Tamassia N; Section of General Pathology, Department of Medicine, University of Verona, Verona, Italy.
Morreale A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Poli P; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Timpano S; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Baresi G; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Zunica F; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Cattalini M; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Moratto D; Flow Cytometry & Clinical Chemistry Laboratory, ASST Spedali Civili, Brescia, Italy.
Chiarini M; Flow Cytometry & Clinical Chemistry Laboratory, ASST Spedali Civili, Brescia, Italy.
Cannizzo ES; Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.
Marchetti G; Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy.
Cassatella MA; Section of General Pathology, Department of Medicine, University of Verona, Verona, Italy.
Taddio A; Pediatric Department, IRCCS Burlo Garofolo, Trieste, Italy.
Tommasini A; Pediatric Department, IRCCS Burlo Garofolo, Trieste, Italy.
Badolato R; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.; 'Angelo Nocivelli' Institute of Molecular Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Mar 26; Vol. 12, pp. 654587. Date of Electronic Publication: 2021 Mar 26 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*immunology
Chemokine CXCL10/*immunology
Chemokine CXCL9/*immunology
Dendritic Cells/*immunology
Interferon-gamma/*immunology
Plasma Cells/*immunology
SARS-CoV-2/*immunology
Systemic Inflammatory Response Syndrome/*immunology
Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Retrospective Studies
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
Role of serum CXCL9 and CXCL13 in predicting infection after kidney transplant: A STROBE study.
Autorzy :
Yan L; Department of Laboratory Medicine.
Li YM; Department of Laboratory Medicine.
Li Y; Department of Laboratory Medicine.
Bai YJ; Department of Laboratory Medicine.
Wan ZL; Department of Laboratory Medicine.
Fan JW; Department of Laboratory Medicine.
Luo LM; Department of Laboratory Medicine.
Wang LL; Department of Laboratory Medicine.
Shi YY; Department of Nephrology, West China Hospital, Sichuan University, No. 37 Guoxue Xiang, Wuhou District, Chengdu, Sichuan, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Mar 19; Vol. 100 (11), pp. e24762.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Chemokine CXCL13/*blood
Chemokine CXCL9/*blood
Infections/*etiology
Kidney Diseases/*blood
Kidney Transplantation/*adverse effects
Postoperative Complications/*etiology
Adult ; Biomarkers/blood ; Chemokine CCL2/blood ; Chemokine CXCL10/blood ; Female ; Humans ; Kidney Diseases/surgery ; Male ; Middle Aged ; Postoperative Period ; Predictive Value of Tests ; Preoperative Period ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Theiler's murine encephalomyelitis virus infection of astrocytes induces the expression of chemokines which attract activated but not resting T lymphocytes.
Autorzy :
Rubio N; Instituto Cajal. C.S.I.C, Dr. Arce Avenue 37, 28002, Madrid, Spain. .
Sanz-Rodriguez F; Department of Biology, Universidad Autonoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło :
Journal of neurovirology [J Neurovirol] 2019 Dec; Vol. 25 (6), pp. 844-852. Date of Electronic Publication: 2019 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Astrocytes/*immunology
Astrocytes/*virology
Cardiovirus Infections/*immunology
Chemokine CXCL9/*immunology
Th1 Cells/*immunology
Animals ; Chemokine CXCL9/biosynthesis ; Chemotaxis, Leukocyte/immunology ; Lymphocyte Activation/immunology ; Mice ; Theilovirus
Czasopismo naukowe
Tytuł :
Genetic Polymorphisms on 4q21.1 Contributed to the Risk of Hashimoto's Thyroiditis.
Autorzy :
Mo D; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Li J; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Peng L; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Liu Z; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Wang J; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Yuan J; Department of General Surgery, Dongguan Tungwah Hospital, Dongguan, China.
Pokaż więcej
Źródło :
Genetic testing and molecular biomarkers [Genet Test Mol Biomarkers] 2019 Dec; Vol. 23 (12), pp. 837-842. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji :
Journal Article
MeSH Terms :
Amidohydrolases/*genetics
Chemokine CXCL9/*genetics
Hashimoto Disease/*genetics
Adult ; Alleles ; Amidohydrolases/metabolism ; Asian Continental Ancestry Group/genetics ; Autoimmune Diseases/genetics ; Case-Control Studies ; Chemokine CXCL9/metabolism ; China ; Chromosomes, Human, Pair 4/genetics ; Female ; Gene Frequency/genetics ; Genetic Predisposition to Disease ; Genotype ; Graves Disease/genetics ; Haplotypes ; Humans ; Male ; Middle Aged ; Phenotype ; Polymorphism, Single Nucleotide/genetics ; Risk Factors
Czasopismo naukowe
Tytuł :
Inhibiting expression of Cxcl9 promotes angiogenesis in MSCs-HUVECs co-culture.
Autorzy :
Shen Q; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China.
Fan X; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China.
Jiang M; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China.
Ye Z; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China.
Zhou Y; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China. Electronic address: .
Tan WS; State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, PR China.
Pokaż więcej
Źródło :
Archives of biochemistry and biophysics [Arch Biochem Biophys] 2019 Oct 30; Vol. 675, pp. 108108. Date of Electronic Publication: 2019 Sep 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neovascularization, Physiologic*
Chemokine CXCL9/*antagonists & inhibitors
Mesenchymal Stem Cells/*cytology
Animals ; Cell Differentiation ; Chemokine CXCL9/metabolism ; Coculture Techniques ; Human Umbilical Vein Endothelial Cells ; Humans ; Osteogenesis ; Protein Binding ; Rats ; STAT1 Transcription Factor/metabolism ; TOR Serine-Threonine Kinases/metabolism ; Vascular Endothelial Growth Factor A/metabolism ; Vascular Endothelial Growth Factor A/physiology
Czasopismo naukowe
Tytuł :
Circular RNA circ_0008450 upregulates CXCL9 expression by targeting miR-577 to regulate cell proliferation and invasion in nasopharyngeal carcinoma.
Autorzy :
Wei H; Department of Gynecology and Pediatrics Nursing, Qiqihar Medical University, Qiqihar 161000, China.
Liu D; Department of Biobank, Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar 161000, China.
Sun J; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar 161000, China.
Mao Y; Department of Pharmacy, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.
Zhao L; Department of Medical Service, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.
Zhu W; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar 161000, China.
Xu G; Department of Microform Experiment Center, College of Pathology, Qiqihar Medical University, Qiqihar 161000, China.
Gao Z; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar 161000, China. Electronic address: .
Pokaż więcej
Źródło :
Experimental and molecular pathology [Exp Mol Pathol] 2019 Oct; Vol. 110, pp. 104288. Date of Electronic Publication: 2019 Jul 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Movement*
Cell Proliferation*
Gene Expression Regulation, Neoplastic*
Chemokine CXCL9/*metabolism
MicroRNAs/*genetics
Nasopharyngeal Carcinoma/*pathology
RNA, Circular/*genetics
Apoptosis ; Chemokine CXCL9/genetics ; Humans ; Nasopharyngeal Carcinoma/genetics ; Nasopharyngeal Carcinoma/metabolism ; Neoplasm Invasiveness ; Signal Transduction ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
miR-588 is a prognostic marker in gastric cancer.
Autorzy :
Chen Y; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Hangzhou, China.; Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Zhang J; Zhejiang Provincial Center for Drug and Medical Device Procurement, Hangzhou, China.
Gong W; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Hangzhou, China.; Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Dai W; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Hangzhou, China.; Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Xu X; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Hangzhou, China.; Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Xu S; The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Hangzhou, China.; Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Pokaż więcej
Źródło :
Aging [Aging (Albany NY)] 2020 Dec 15; Vol. 13 (2), pp. 2101-2117. Date of Electronic Publication: 2020 Dec 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma/*genetics
Lymphocytes, Tumor-Infiltrating/*immunology
MicroRNAs/*genetics
Stomach Neoplasms/*genetics
Adenocarcinoma/immunology ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Animals ; CD4-Positive T-Lymphocytes ; CD8-Positive T-Lymphocytes ; Cell Line, Tumor ; Cell Proliferation/genetics ; Chemokine CXCL10/genetics ; Chemokine CXCL10/immunology ; Chemokine CXCL5/genetics ; Chemokine CXCL5/immunology ; Chemokine CXCL9/genetics ; Chemokine CXCL9/immunology ; Gene Knock-In Techniques ; Humans ; In Vitro Techniques ; Mice ; Mice, Nude ; MicroRNAs/immunology ; Neoplasm Transplantation ; Reverse Transcriptase Polymerase Chain Reaction ; Stomach Neoplasms/immunology ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies